ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rutten-van Molken, M.
Right arrow Articles by Raaijmakers, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rutten-van Molken, M.
Right arrow Articles by Raaijmakers, J.
Eur Respir J 1995; 8: 888-898
Copyright © ERS Journals Ltd 1995


Clinical Trial

Comparison of performance of four instruments in evaluating the effects of salmeterol on asthma quality of life

MP Rutten-van Molken, F Custers, EK van Doorslaer, CC Jansen, L Heurman, FP Maesen, JJ Smeets, AM Bommer, and JA Raaijmakers

Quality of life measures are increasingly used as important efficacy endpoints in studies of drugs for asthma. The purpose of this study was to assess both the sensitivity to change and the construct validity of four different quality of life instruments in patients with asthma. In a double-blind, parallel group study, 120 moderate asthma patients, aged between 18-70 yrs, received either inhaled salmeterol 50 micrograms b.i.d. or inhaled salbutamol 400 micrograms b.i.d. In addition to respiratory outcomes, quality of life was measured at a 6 weeks follow-up using: 1) Asthma Quality of Life Questionnaire (AQLQ); 2) Living With Asthma Questionnaire (LWAQ); 3) Sickness Impact Profile (SIP); 4) Rating Scale (RS); and Standard Gamble (SG) utilities. Salmeterol led to significant improvements over salbutamol on virtually all clinical outcomes. Although all the quality of life instruments showed the same trend in favour of salmeterol, only the AQLQ and RS utilities showed significantly greater improvement on salmeterol than on salbutamol. Except for the AQLQ, the correlation between change in lung function and change in quality of life was generally low. Whereas, the AQLQ correlated well with the patient's overall assessment of efficacy (r = 0.64), the LWAQ, SIP and utilities failed to show such a correlation. The AQLQ showed the best correlation with symptom scores. The cross-sectional correlation between the AQLQ and the LWAQ was 0.73, whereas the longitudinal correlation was only 0.29. The SG generally showed poor correlation with other measures, including the RS. In conclusion, patients given salmeterol showed a greater improvement in quality of life compared to patients given salbutamol. Of the disease-specific questionnaires the Asthma Quality of Life Questionnaire was found to be more responsive to change than the Living With Asthma Questionnaire and showed greater validity. Of the generic instruments, the rating scale utilities were most responsive. The Standard Gamble showed poor correlation with other measures.


This article has been cited by other articles:


Home page
Med Decis MakingHome page
M. O. Edelen, M. A. Burnam, K. E. Watkins, J. J. Escarce, H. Huskamp, H. H. Goldman, and G. Rachelefsky
Obtaining Utility Estimates of the Health Value of Commonly Prescribed Treatments for Asthma and Depression
Med Decis Making, September 1, 2008; 28(5): 732 - 750.
[Abstract] [PDF]


Home page
ThoraxHome page
M. G Pearson
Breathing exercises for asthma: panacea or placebo?
Thorax, December 1, 2007; 62(12): 1033 - 1034.
[Full Text] [PDF]


Home page
Hum ReprodHome page
S. Ferrero, P. Petrera, B.M. Colombo, R. Navaratnarajah, M. Parisi, P. Anserini, V. Remorgida, and N. Ragni
Asthma in women with endometriosis
Hum. Reprod., December 1, 2005; 20(12): 3514 - 3517.
[Abstract] [Full Text] [PDF]


Home page
Clin Nurs ResHome page
C. J. M. Ross, T. M. A. Davis, and G. F. Macdonald
Cognitive-Behavioral Treatment Combined With Asthma Education for Adults With Asthma and Coexisting Panic Disorder
Clin Nurs Res, May 1, 2005; 14(2): 131 - 157.
[Abstract] [PDF]


Home page
ChestHome page
M. Albers, T. Schermer, G. van den Boom, R. Akkermans, C. van Schayck, C. van Herwaarden, and C. van Weel
Efficacy of Inhaled Steroids in Undiagnosed Subjects at High Risk for COPD: Results of the Detection, Intervention, and Monitoring of COPD and Asthma Program
Chest, December 1, 2004; 126(6): 1815 - 1824.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
E.F. Juniper, M.E. Wisniewski, F.M. Cox, A.H. Emmett, K.E. Nielsen, and P.M. O'Byrne
Relationship between quality of life and clinical status in asthma: a factor analysis
Eur. Respir. J., February 1, 2004; 23(2): 287 - 291.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
T. R. Schermer, B. P. Thoonen, G. van den Boom, R. P. Akkermans, R. P. Grol, H. T. Folgering, C. van Weel, and C. P. van Schayck
Randomized Controlled Economic Evaluation of Asthma Self-Management in Primary Health Care
Am. J. Respir. Crit. Care Med., October 15, 2002; 166(8): 1062 - 1072.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
T. Oga, K. Nishimura, M. Tsukino, S. Sato, T. Hajiro, and M. Mishima
Comparison of the Responsiveness of Different Disease-Specific Health Status Measures in Patients With Asthma
Chest, October 1, 2002; 122(4): 1228 - 1233.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
E.D. Bateman, L.F. Frith, and G.L. Braunstein
Achieving guideline-based asthma control: does the patient benefit?
Eur. Respir. J., September 1, 2002; 20(3): 588 - 596.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
P.W. Jones
Interpreting thresholds for a clinically significant change in health status in asthma and COPD
Eur. Respir. J., March 1, 2002; 19(3): 398 - 404.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
G. VAN DEN BOOM, M. P. M. H. RUTTEN-VAN MOLKEN, J. MOLEMA, P. R. S. TIRIMANNA, C. VAN WEEL, and C. P. VAN SCHAYCK
The Cost Effectiveness of Early Treatment with Fluticasone Propionate 250 {micro}g Twice a Day in Subjects with Obstructive Airway Disease . Results of the DIMCA Program
Am. J. Respir. Crit. Care Med., December 1, 2001; 164(11): 2057 - 2066.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
E.F. Juniper, G.R. Norman, F.M. Cox, and J.N. Roberts
Comparison of the standard gamble, rating scale, AQLQ and SF-36 for measuring quality of life in asthma
Eur. Respir. J., July 1, 2001; 18(1): 38 - 44.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. L. MOY, E. ISRAEL, S. T. WEISS, E. F. JUNIPER, L. DUBÉ, J. M. DRAZEN, and the NHLBI Asthma Clinical Rese
Clinical Predictors of Health-related Quality of Life Depend on Asthma Severity
Am. J. Respir. Crit. Care Med., March 15, 2001; 163(4): 924 - 929.
[Abstract] [Full Text]


Home page
ThoraxHome page
L M Osman, L McKenzie, J Cairns, J A R Friend, D J Godden, J S Legge, and J G Douglas
Patient weighting of importance of asthma symptoms
Thorax, February 1, 2001; 56(2): 138 - 142.
[Abstract] [Full Text]


Home page
ThoraxHome page
H Moudgil, T Marshall, and D Honeybourne
Asthma education and quality of life in the community: a randomised controlled study to evaluate the impact on white European and Indian subcontinent ethnic groups from socioeconomically deprived areas in Birmingham, UK
Thorax, March 1, 2000; 55(3): 177 - 183.
[Abstract] [Full Text]


Home page
Am. J. Respir. Crit. Care Med.Home page
L. M. OSMAN, C. CALDER, R. ROBERTSON, J. A. R. FRIEND, J. S. LEGGE, and J. GRAHAM DOUGLAS
Symptoms, Quality of Life, and Health Service Contact among Young Adults with Mild Asthma
Am. J. Respir. Crit. Care Med., February 1, 2000; 161(2): 498 - 503.
[Abstract] [Full Text]


Home page
ChestHome page
E. F. Juniper and A. S. Buist
Health-Related Quality of Life in Moderate Asthma: 400 {micro}g Hydrofluoroalkane Beclomethasone Dipropionate vs 800 {micro}g Chlorofluorocarbon Beclomethasone Dipropionate
Chest, November 1, 1999; 116(5): 1297 - 1303.
[Abstract] [Full Text] [PDF]


Home page
Med Decis MakingHome page
C. A.E. Nickerson
Assessing Convergent Validity of Health-state Utilities Obtained Using Different Scaling Methods
Med Decis Making, October 1, 1999; 19(4): 487 - 498.
[Abstract] [PDF]


Home page
ChestHome page
E. F. Juniper, A. S. Buist, F. M. Cox, P. J. Ferrie, and D. R. King
Validation of a Standardized Version of the Asthma Quality of Life Questionnaire
Chest, May 1, 1999; 115(5): 1265 - 1270.
[Abstract] [Full Text] [PDF]


Home page
Fam PractHome page
B. G. Bentsen, B. Natvig, and M. Winnem
Questions you didn't ask? COOP/WONCA Charts in clinical work and research
Fam. Pract., April 1, 1999; 16(2): 190 - 195.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
R. F. Lockey, L. M. DuBuske, B. Friedman, V. Petrocella, F. Cox, and K. Rickard
Nocturnal Asthma: Effect of Salmeterol on Quality of Life and Clinical Outcomes
Chest, March 1, 1999; 115(3): 666 - 673.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
N. K. LEIDY, K. S. CHAN, and C. COUGHLIN
Is the Asthma Quality of Life Questionnaire a Useful Measure for Low-income Asthmatics?
Am. J. Respir. Crit. Care Med., October 1, 1998; 158(4): 1082 - 1090.
[Abstract] [Full Text] [PDF]


Home page
Eval Health ProfHome page
U. Nanda and E. M. Andresen
Health-Related Quality of Life: A Guide for the Health Professional
Eval Health Prof, June 1, 1998; 21(2): 179 - 215.
[Abstract] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
J. R. CURTIS, D. P. MARTIN, and T. R. MARTIN
Patient-assessed Health Outcomes in Chronic Lung Disease . What are They, How Do They Help Us, and Where Do We Go From Here?
Am. J. Respir. Crit. Care Med., October 1, 1997; 156(4): 1032 - 1039.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 by the European Respiratory Society.